Literature DB >> 17259413

Hydroxyapatite-coated total knee replacement: clinical experience at 10 to 15 years.

J-A Epinette1, M T Manley.   

Abstract

This study describes 146 primary total knee replacements, either fully or partially coated with hydroxyapatite of which 74 knees in 68 patients were available for clinical and radiological assessment at a mean of 11.2 years (10 to 15). The global failure rate was 1.37% and survival rate with mechanical failure as the end-point was 98.14%. Radiological assessment indicated intimate contact between bone and the hydroxyapatite coating. Over time the hydroxyapatite coating appears to encourage filling of interface gaps remaining after surgery. Our results compare favourably with those of series describing cemented or porous-coated knee replacements, and suggest that fixation with hydroxyapatite is a reliable option in primary total knee replacement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259413     DOI: 10.1302/0301-620X.89B1.17864

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  18 in total

1.  Long lasting outcome of hydroxyapatite-coated implants in primary knee arthroplasty: a continuous series of two hundred and seventy total knee arthroplasties at fifteen to twenty two years of clinical follow-up.

Authors:  Jean-Alain Epinette
Journal:  Int Orthop       Date:  2014-01-03       Impact factor: 3.075

2.  Comparison of patellar resurfacing versus preservation in high flexion total knee arthroplasty.

Authors:  Seong Hwan Kim; Sahnghoon Lee; Du Hyun Ro; Yool Cho; Young Min Lee; Kee Yun Chung; Myung Chul Lee
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-09-16       Impact factor: 4.342

3.  Does computer-assisted surgery influence survivorship of cementless total knee arthroplasty in patients with primary osteoarthritis? A 10-year follow-up study.

Authors:  Hervé Ouanezar; Florent Franck; Alexandre Jacquel; Vincent Pibarot; Julien Wegrzyn
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-07       Impact factor: 4.342

Review 4.  The biological response to orthopaedic implants for joint replacement: Part I: Metals.

Authors:  Emmanuel Gibon; Derek F Amanatullah; Florence Loi; Jukka Pajarinen; Akira Nabeshima; Zhenyu Yao; Moussa Hamadouche; Stuart B Goodman
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2016-06-21       Impact factor: 3.368

5.  Unicompartmental versus total knee arthroplasty database analysis: is there a winner?

Authors:  Matthew C Lyons; Steven J MacDonald; Lyndsay E Somerville; Douglas D Naudie; Richard W McCalden
Journal:  Clin Orthop Relat Res       Date:  2012-01       Impact factor: 4.176

6.  Preoperative activity levels are an important indicator of postoperative activity in cementless TKAs.

Authors:  Jeremy A Dubin; Geoffrey H Westrich
Journal:  J Orthop       Date:  2020-11-17

Review 7.  Highlighting the advantages and benefits of cementless total knee arthroplasty (Review).

Authors:  Bogdan Uivaraseanu; Cosmin Mihai Vesa; Delia Mirela Tit; Octavian Maghiar; Teodor Andrei Maghiar; Calin Hozan; Aurelia Cristina Nechifor; Tapan Behl; Felicia Liana Andronie-Cioara; Jenel Marian Patrascu; Simona Bungau
Journal:  Exp Ther Med       Date:  2021-11-18       Impact factor: 2.447

8.  Long-term results of Alpina Postero-stabilized total knee replacement: 10- to 16-year follow-up.

Authors:  François Lecuire; Julien Henry; Benjamin Francois; Jérôme Rubini; Maurice Basso
Journal:  Eur J Orthop Surg Traumatol       Date:  2011-11-06

9.  Cementless and cemented total knee arthroplasty in patients younger than fifty five years. Which is better?

Authors:  Young-Hoo Kim; Jang-Won Park; Hyung-Mook Lim; Eun-Soo Park
Journal:  Int Orthop       Date:  2014-01-14       Impact factor: 3.075

10.  Good long-term results following cementless TKA with a titanium plasma coating.

Authors:  Theodore Bouras; Vasileios Bitas; Peter Fennema; Panagiotis Korovessis
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-09-03       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.